Cargando…
SARS-CoV-2 variants: Impact on biological and clinical outcome
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that was first identified in December 2019, in Wuhan, China was found to be the etiological agent for a novel respiratory infection that led to a Coronavirus Induced Disease named COVID-19. The disease spread to pandemic magnitudes wit...
Autores principales: | Mahilkar, Shakuntala, Agrawal, Sachee, Chaudhary, Sakshi, Parikh, Swapneil, Sonkar, Subash C., Verma, Dileep Kumar, Chitalia, Vidushi, Mehta, Divya, Koner, Bidhan Chandra, Vijay, Neetu, Shastri, Jayanthi, Sunil, Sujatha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685312/ https://www.ncbi.nlm.nih.gov/pubmed/36438034 http://dx.doi.org/10.3389/fmed.2022.995960 |
Ejemplares similares
-
Severe SARS-CoV-2 Breakthrough Reinfection With Delta Variant After Recovery From Breakthrough Infection by Alpha Variant in a Fully Vaccinated Health Worker
por: Shastri, Jayanthi, et al.
Publicado: (2021) -
Clinical, Serological, Whole Genome Sequence Analyses to Confirm SARS-CoV-2 Reinfection in Patients From Mumbai, India
por: Shastri, Jayanthi, et al.
Publicado: (2021) -
Seroprevalence of Hepatitis B and Hepatitis C virus infection among HIV infected patients in Mumbai
por: Sawant, Sandhya, et al.
Publicado: (2010) -
Pediatric HIV in Mumbai
por: Agrawal, Sachee, et al.
Publicado: (2011) -
Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India
por: Shastri, Jayanthi, et al.
Publicado: (2022)